Addressing Treatment Gaps in Adult Patients with ADHD
Addressing Treatment Gaps in Adult Patients with ADHD
This CME activity is based on the slides and lecture presented by the faculty at the Psych Congress 1-Day Regional Meeting in San Francisco, CA on Saturday, February 28, 2016.
Rakesh Jain, MD, MPH
Department of Psychiatry
Texas Tech Health Sciences Center
School of Medicine
Saundra Jain, MA, PsyD, LPC
Adjunct Clinical Affiliate
University of Texas at Austin School of Nursing
This activity is designed for psychiatrists, primary care physicians, psychologists, nurse practitioners, physician assistants, psychiatric nurses, and other healthcare professionals involved in treating patients with attention-deficit/hyperactivity disorder.
After completing this activity, participants should be able to:
- Utilize validated screening tools to properly identify adult patients with suspected attention-deficit/hyperactivity disorder (ADHD)
- Properly employ updated DSM-5 criteria for the diagnosis of ADHD, while identifying and distinguishing from its comorbid disorders
- Discuss new and emerging evidence-based treatments for adult ADHD, including benefits such as extended duration and improved executive function
- Translate the latest clinical data to informed treatment selection and improved management of adult patients with ADHD
This on-demand webcast is available with synchronized slides and audio.
To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form.
After successful completion of the post-test and evaluation form, participants may immediately print their documentation of credit.
Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.
Release Date: March 31, 2016
Expiration Date: March 31, 2017
Estimated time to complete: 0.75 hour
There is no fee associated with this activity.
For questions regarding this educational activity, please call 609-371-1137.
North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
NACCME designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing nursing education activity awards 0.75 contact hours.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 0.75 contact hour.
For faculty bios, please call 609-371-1137.
Independent Clinical Reviewer: William C. Torrey, MD, Professor of Psychiatry, Vice Chair for Clinical Services, Department of Psychiatry, Grisel School of Medicine at Dartmouth, Lebanon, New Hampshire
Nurse Planner: Andrew Penn, RN, MS, NP, CNS, APRN-BC, Psychiatric Nurse Practitioner, Kaiser Permanente, Redwood City, California; Assistant Clinical Professor, University of California, San Francisco, California
The planning committee comprises Rakesh Jain, MD, MPH, Saundra Jain, MA, PsyD, LPC, William C. Torrey, MD, Andrew Penn, RN, MS, NP, CNS, APRN-BC; Raquel Gaerlan, Michelle Montgomery, Meaghan O’Brien, Randy Robbin, and John Savage NACCME.
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. R. Jain: Advisory Board—Addrenex, Alkermes, Forum, Lilly, Lundbeck, Merck, Neos Therapeutics, Otsuka, Pamlab, Pfizer, Shionogi, Shire, Sunovion, Takeda; Consultant—Addrenex, Forest, Lilly (and spouse), Lundbeck, Merck, Otsuka (and spouse), Pamlab (and spouse), Pfizer, Shionogi, Shire, Sunovion, Takeda; Grant/Research Support—AstraZeneca, Forest, Lilly, Lundbeck, Otsuka, Pfizer, Shire, Takeda; Speakers’ Bureau—Addrenex, Alkermes, Forest, Lilly, Lundbeck, Merck, Otsuka, Pamlab, Pfizer, Rhodes Pharmaceuticals, Shionogi, Shire, Sunovion
Dr. S. Jain: Consultant—Lilly, Otsuka, Pamlab; Spouse—Advisory Board—Addrenex, Alkermes, Forum, Lilly, Lundbeck, Merck, Neos Therapeutics, Otsuka, Pamlab, Pfizer, Shionogi, Shire, Sunovion, Takeda; Consultant—Addrenex, Forest, Lilly, Lundbeck, Merck, Otsuka, Pamlab, Pfizer, Shionogi, Shire, Sunovion, Takeda; Grant/Research Support—AstraZeneca, Forest, Lilly, Lundbeck, Otsuka, Pfizer, Shire, Takeda; Speakers’ Bureau—Addrenex, Alkermes, Forest, Lilly, Lundbeck, Merck, Otsuka, Pamlab, Pfizer, Rhodes Pharmaceuticals, Shionogi, Shire, Sunovion
Mr. Penn and Dr. Torrey disclosed no relevant financial relationships with any commercial interests.
Raquel Gaerlan, Michelle Montgomery, Meaghan O’Brien, Randy Robbin, and John Savage have disclosed no relevant financial relationships with any commercial interests.
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.
The faculty has disclosed that no off-label/unapproved uses of drugs and/or devices will be discussed.
All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested for video programs. A PDF reader is required for print publications. Please direct technical questions email@example.com.
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, expect such information as it is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2016 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in the educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
Supported by an independent educational grant from Shire.